Sponsor or institution
Clinical trials and research at Vall d'Hebron Institute of Oncology
As of November 12, 2026, Find a Trial lists 8 clinical trials run by Vall d'Hebron Institute of Oncology that are recruiting, at sites in 7 countries (most in Spain (8), France (1), Germany (1)). By phase: Phase 2 (5), Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 7Countries
Newest trials
All recruiting trials (8)
-
Autologous p95HER2 CAR-T Cells in HER2-Positive Cancers
This study tests whether a patient’s own CAR-T cells targeting p95HER2 can be safely given to adults with HER2-positive metastatic cancers to see if it can help control tumors.
-
Evaluating immunotherapy for colorectal and endometrial cancer
This study is testing a new immunotherapy treatment for people with colorectal or endometrial cancer to see if a combination of two drugs can help them better than just one.
-
Evaluating the safety and effectiveness of OMO-103 for advanced high-grade osteosarcoma
This study is testing a new treatment called OMO-103 to see if it can safely help people with advanced high-grade osteosarcoma.
-
Comparing two treatments for melanoma, lung cancer, and cervical cancer using immune cells
This study is testing two different immune treatments to see which one works better and has fewer side effects for patients with advanced melanoma, lung cancer, and cervical cancer who are receiving special cell therapy.
-
Combination therapy for metastatic colorectal cancer with BRAF-V600E mutation
This study is testing a new combination of three drugs to see if it can help people with advanced colorectal cancer that has a specific mutation feel better and live longer after their previous treatments stopped working.
-
Identifying biomarkers for treatment response in triple negative breast cancer
This study is testing if certain biological markers in tissue samples can help doctors predict how well treatments will work for people with stage II-III triple negative breast cancer.
-
Testing a new immune therapy for advanced solid tumors resistant to standard treatments
This study is testing a new immune therapy that uses special cells from patients' tumors to see if it can help people with advanced solid tumors that haven't responded to standard treatments.
-
Personalized cancer treatment using targeted therapies based on genetic mutations
This study is testing if personalized cancer treatments that match therapies to specific genetic changes in advanced solid tumors can help patients feel better and improve their outcomes.
Quick answers
How many clinical trials run by Vall d'Hebron Institute of Oncology are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Spain (8 trials), France (1 trial), Germany (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.